Innominds and SCIINV Biosciences unveil AI-driven solution to combat AMR in India
06th June, 2024
Cutting-edge digital diagnostic tool eliminates need for traditional culture methods
image credit- shutterstock
Innominds, a US-based digital transformation and product engineering company, has announced its partnership with Hyderabad-based startup SCIINV Biosciences to introduce AMRx, an advanced AI/ML-driven digital diagnostic tool designed to combat the growing threat of antimicrobial resistance (AMR).
This innovative tool promises to revolutionise the detection and treatment of antibiotic-resistant infections without the need for traditional cultures.
AMRx, developed by Innominds and SCIINV Biosciences, is a groundbreaking, culture-free companion diagnostic tool that utilises AI/ML to predict Urinary Tract Infections (UTIs) and determine antibiotic resistance patterns based on patient clinical history. This patented technology represents a significant advancement in the fight against AMR.
AMRx leverages patient clinical history to accurately predict UTIs, identify causative organisms (Enterobacteriaceae), and determine antibiotic resistance or susceptibility patterns without the need for traditional cultures.
By reducing unwarranted clinical investigations, AMRx saves valuable time, effort, and resources. This efficiency is particularly beneficial in resource-limited settings.
AMRx can be deployed as a clinical decision support tool, aiding healthcare professionals in making appropriate empirical antibiotic prescriptions, thereby enhancing the accuracy and effectiveness of treatment.
Medtech Special
- Chi Mei Medical Center and Microsoft: Transforming Healthcare with AI and Smart Technology
- From Acute Care to AI: Executive Vice President, Kang-Yun Lee Talks Taiwan Medical University Hospital’s Smart Healthcare Revolution
- Taiwan Healthcare+ Expo 2024 Leads the Way in Global Medical Innovation
- Breaking Boundaries in Cancer Care: The 4th Asia Pacific Forum on Precision Treatment
- AI and Biotech Revolution Take Center Stage at Healthcare+ Expo Taiwan 2024
- Healthcare+ Expo Taiwan 2024: The Future of Healthcare Unfolds in Taipei
- Australia's Peter MacCallum Cancer Centre partners with GE HealthCare to advance cancer research
Artificial Intelligence Breakthroughs
- India-based 'Mahajan Imaging and Labs' launches AI-powered lab in Gurugram
- Saudi Arabia to develop AI and data science solution for tackling tuberculosis
- How AI is Propelling Radiology & Medical Imaging Capabilities
- Generative AI: Revolutionizing Diagnostics and Personalized Care
- Indian startup Qure.ai joins hands with Roche to transform healthcare capabilities in APAC
- A10 Networks Launches Integrated AI and Security Solutions to Strengthen Cybersecurity in Healthcare and Beyond
- deepc and AI Centre for Value-Based Healthcare enter a partnership
Robots In Medtech
- India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
- First-of-its-kind robotic cardiac CoE unveiled in Bengaluru, India
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer